Home/Filings/4/0001649094-24-000121
4//SEC Filing

PICKERING GRANT 4

Accession 0001649094-24-000121

CIK 0001649094other

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 4:10 PM ET

Size

12.2 KB

Accession

0001649094-24-000121

Insider Transaction Report

Form 4
Period: 2024-12-09
PICKERING GRANT
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Sale

    Common Stock

    2024-12-09$93.10/sh222$20,668136,215 total(indirect: By Trust)
  • Sale

    Common Stock

    2024-12-09$92.06/sh961$88,470136,437 total(indirect: By Trust)
  • Sale

    Common Stock

    2024-12-09$92.03/sh1,029$94,701136,369 total(indirect: By Trust)
  • Sale

    Common Stock

    2024-12-09$93.60/sh154$14,414136,215 total(indirect: By Trust)
Holdings
  • Common Stock

    450,301
Footnotes (7)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024.
  • [F2]The price reported is a weighted-average price. The shares were sold at prices ranging from $91.615 to $92.61. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
  • [F4]The price reported is a weighted-average price. The shares were sold at prices ranging from $92.80 to $93.68. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F5]The price reported is a weighted-average price. The shares were sold at prices ranging from $91.715 to $92.63. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F6]Shares are held directly by a trust for the benefit of the Reporting Person's son.
  • [F7]The price reported is a weighted-average price. The shares were sold at prices ranging from $93.355 to $93.72. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Issuer

Vaxcyte, Inc.

CIK 0001649094

Entity typeother

Related Parties

1
  • filerCIK 0001258693

Filing Metadata

Form type
4
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 4:10 PM ET
Size
12.2 KB